BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15517940)

  • 1. [Dysmetabolic syndrome].
    Jołda-Mydłowska B
    Pol Merkur Lekarski; 2004 Apr; 16(94):385-8. PubMed ID: 15517940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dysmetabolic symptomatic arterial hypertension and dysmetabolic disease].
    Bokarev IN; Shubina OI
    Klin Med (Mosk); 2009; 87(8):67-71. PubMed ID: 19827536
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
    Wasir JS; Misra A; Vikram NK; Pandey RM; Gupta R
    J Assoc Physicians India; 2008 Mar; 56():158-64. PubMed ID: 18697631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial.
    Daly CA; Hildebrandt P; Bertrand M; Ferrari R; Remme W; Simoons M; Fox KM;
    Heart; 2007 Nov; 93(11):1406-11. PubMed ID: 17540689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome at age 16 using the International Diabetes Federation paediatric definition.
    Pirkola J; Tammelin T; Bloigu A; Pouta A; Laitinen J; Ruokonen A; Tapanainen P; Järvelin MR; Vääräsmäki M
    Arch Dis Child; 2008 Nov; 93(11):945-51. PubMed ID: 18456683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome and cardiovascular risk level in a vulnerable population.
    Kim CJ; Park J; Kang SW
    Int J Nurs Pract; 2015 Apr; 21(2):175-83. PubMed ID: 24666551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive disorders and the metabolic syndrome of insulin resistance.
    Petrlová B; Rosolova H; Hess Z; Podlipný J; Simon J
    Semin Vasc Med; 2004 May; 4(2):161-5. PubMed ID: 15478037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage.
    Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G
    Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
    Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG
    Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.
    Hu G; Qiao Q; Tuomilehto J; Balkau B; Borch-Johnsen K; Pyorala K;
    Arch Intern Med; 2004 May; 164(10):1066-76. PubMed ID: 15159263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The metabolic syndrome].
    Pelikánová T
    Vnitr Lek; 2003 Dec; 49(12):900-6. PubMed ID: 15040152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS).
    Hosseinpanah F; Barzin M; Sheikholeslami F; Azizi F
    Am J Cardiol; 2011 Feb; 107(3):412-6. PubMed ID: 21257007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation.
    Ford ES; Li C; Zhao G; Pearson WS; Mokdad AH
    Diabetes Care; 2008 Mar; 31(3):587-9. PubMed ID: 18071007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects.
    Lee WY; Park JS; Noh SY; Rhee EJ; Kim SW; Zimmet PZ
    Diabetes Res Clin Pract; 2004 Aug; 65(2):143-9. PubMed ID: 15223226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome in urban city of North-Western Nigeria: prevalence and determinants.
    Sabir AA; Jimoh A; Iwuala SO; Isezuo SA; Bilbis LS; Aminu KU; Abubakar SA; Saidu Y
    Pan Afr Med J; 2016; 23():19. PubMed ID: 27200125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome among hypertensive patients attending a primary care clinic in Kuwait.
    Sorkhou EI; Al-Qallaf B; Al-Namash HA; Ben-Nakhi A; Al-Batish MM; Habiba SA
    Med Princ Pract; 2004; 13(1):39-42. PubMed ID: 14657618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiological characterization of metabolic syndrome in overweight, obese and type 2 diabetic Algerian subjects: interest of adipokines as dysmetabolic biomarkers].
    Benbaibeche H; Haffaf el M; Kacimi G; Oudjit B; Koceir E
    Ann Biol Clin (Paris); 2014; 72(4):463-72. PubMed ID: 25119805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.